Beta blocker overdose management
Pro Research Analysisby 
Searched over 200M research papers
Clinical Presentation and Initial Assessment in Beta Blocker Overdose
Beta blocker overdose can be life-threatening, often presenting with bradycardia, hypotension, and, in severe cases, cardiogenic shock or cardiac arrest. Patients may initially be asymptomatic but can rapidly deteriorate, highlighting the need for prompt recognition and intervention 3568+1 MORE. Mental status changes and seizures may also occur in severe cases 26.
Early Management: Supportive Care and Decontamination
Immediate management includes close monitoring of vital signs and cardiac rhythm. For patients presenting soon after ingestion, early gastric decontamination with activated charcoal can be beneficial and potentially lifesaving, especially if administered within the first hour of overdose 29. Supportive care with intravenous fluids is essential to maintain blood pressure and perfusion 269.
First-Line Pharmacologic Interventions: Glucagon and Atropine
When bradycardia and hypotension develop, intravenous glucagon is considered the first-line antidote for beta blocker toxicity, as it can improve heart rate and blood pressure 2910. Atropine may also be used to treat bradycardia, though its effectiveness can be inconsistent 269. Vasopressors and catecholamines are often required to support blood pressure and cardiac output, providing survival benefits in many cases 369.
Advanced Therapies: High-Dose Insulin Euglycemic Therapy (HIET)
High-dose insulin euglycemic therapy (HIET) is increasingly recognized as an effective treatment for severe or refractory beta blocker overdose. HIET improves cardiac contractility and can reverse shock, even when vasopressors are insufficient 1346+2 MORE. Recent guidelines recommend early initiation of HIET in severe cases, with dosing starting at 1 unit/kg IV bolus followed by continuous infusion, alongside dextrose to prevent hypoglycemia and frequent monitoring for electrolyte disturbances 4679. HIET has shown mortality benefits and rapid hemodynamic improvement in both case reports and case series 1479.
Additional and Rescue Therapies
Other treatments, such as intravenous calcium, may provide some hemodynamic improvement, though evidence is less robust compared to HIET and vasopressors 369. Intravenous lipid emulsion therapy and methylene blue have been used in select cases, but responses are variable and typically reserved for refractory situations . Temporary cardiac pacing may be considered for arrhythmias, and extracorporeal membrane oxygenation (ECMO) is an option for patients with persistent shock or cardiac arrest unresponsive to medical therapy 369.
Special Considerations
The effectiveness of interventions can vary depending on the specific beta blocker involved and the timing of presentation. Hemodialysis may be helpful for certain water-soluble beta blockers like atenolol, but is generally not effective for most agents due to their lipophilicity and protein binding 69. Most cases require a combination of therapies, and treatment should be tailored to the patient’s clinical status and response 69.
Conclusion
Beta blocker overdose is a medical emergency requiring rapid assessment and a stepwise approach to management. Early decontamination, supportive care, and first-line pharmacologic interventions such as glucagon and vasopressors are critical. High-dose insulin euglycemic therapy is now strongly recommended for severe or refractory cases, with ECMO as a last resort. Early recognition and aggressive, protocol-driven management can significantly improve outcomes in beta blocker toxicity 1234+4 MORE.
Sources and full results
Most relevant research papers on this topic